Imaging Technology News

July 10, 2026 — A new study led by researchers at the Icahn School of Medicine at Mount Sinai found that although the overall number of radiation oncology clinics in the United States has appeared stable in recent years, many individual treatment centers have quietly closed while others have opened. The closures have disproportionately affected rural and freestanding practices, reducing access to lifesaving radiation therapy for patients to receive lifesaving cancer treatment close to home.

July 9, 2026 — Viz.ai has announced a collaboration with Cortechs.ai to integrate Cortechs.ai's NeuroQuant and NeuroQuant MS suite into the Viz.ai platform, expanding access to quantitative neuroimaging for hospitals and health systems across the U.S. This partnership marks Viz.ai's expansion into neurodegenerative disease, growing Viz Neuro Suite beyond its neuro offerings.

July 8, 2026 — Freeland Systems, a cloud PACS and clinical imaging software company, has launched its new customer dashboard, a portal built specifically for AccessPoint PACS users. The dashboard brings system status, documentation, video training and support resources into a single screen, reflecting Freeland Systems' shift toward more proactive customer support. The launch comes as cloud based PACS adoption accelerates industry wide.

July 7, 2026 — Longeviti Neuro Solutions has launched two strategic initiatives, ClearFit AI, a Brain Ultrasound Interface (BUI).These technologies create a persistent acoustic interface to the brain, enabling real-time bedside imaging and supporting future advances in neurosurgical care.

July 8, 2026 — GE HealthCare and Mayo Clinic have announced the MI-BET (Molecular Imaging Biomarker-Based End of Therapy Trial) research collaboration, a novel theranostics study designed to explore a more personalized approach to radioligand therapy (RLT) for patients with advanced prostate cancer.

July 8,2026 — CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, has announced the integration of the ArteraAI Prostate Test into its diagnostic workflows. It is the first laboratory in Puerto Rico to bring this guideline-recommended AI test into routine clinical use, allowing for fast and convenient delivery of treatment insights.

July 7, 2026 — Imagion Biosystems, Ltd. recently announced it has renewed and extended its collaboration agreement with Siemens Healthineers to support the company’s Phase 2 clinical trial of the MagSense imaging agent in patients with HER2+ breast cancer. The extended collaboration comes on the heels of a series of milestones for the company, which recently announced FDA clearance for a Phase 2 clinical trial with MagSense.

July 7, 2026 — QT Imaging Holdings, Inc. recently announced it has successfully completed its first routine inspection by the U.S. Food and Drug Administration (FDA), with zero Form 483 observations. The FDA inspection reviewed QT Imaging’s Quality Management System (QMS) and related processes that support the company’s operations, with no Form 483 observations issued.

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which automatically identifies suspected lesions on breast MRI. QP-Breast assists radiologists during the interpretation of breast MRI studies by providing accurate detection of lesions suspicious for breast cancer and generating clear, user-friendly reports that slot into existing hospital systems.

June 29, 2026 – GE HealthCare has introduced Allia platform upgrade pathways designed to help customers modernize select Innova, Discovery and Allia Image Guiding Solutions (IGS) systems. These pathways provide access to Allia technologies and workflows that support efficiency and procedural decision-making while helping preserve existing infrastructure, avoid major construction work, extend interventional room lifetime and minimize disruption to clinical operations.